Riazi S - Search Results

1

Association between known or strongly suspected malignant hyperthermia susceptibility and postoperative outcomes: an observational population-based study.

Jones PM, Allen BN, Cherry RA, Dubois L, Vogt KN, Shariff SZ, Bray Jenkyn KM, Riazi S, Wijeysundera DN. Jones PM, et al. Among authors: riazi s. Can J Anaesth. 2019 Feb;66(2):161-181. doi: 10.1007/s12630-018-1250-8. Epub 2018 Nov 12. Can J Anaesth. 2019. PMID: 30421146 English.

2

O'Connor TN, van den Bersselaar LR, Chen YS, Nicolau S, Simon B, Huseth A, Todd JJ, Van Petegem F, Sarkozy A, Goldberg MF, Voermans NC, Dirksen RT; RYR1 Myopathy Consortium. O'Connor TN, et al. J Neuromuscul Dis. 2023;10(1):135-154. doi: 10.3233/JND-221609. J Neuromuscul Dis. 2023. PMID: 36404556 Free PMC article. No abstract available.

3

Synchronizing systolic calcium release with azumolene in an experimental model.

Si D, Chakraborty P, Azam MA, Nair MKK, Massé S, Lai PFH, Labos C, Riazi S, Nanthakumar K. Si D, et al. Among authors: riazi s. Heart Rhythm O2. 2022 Jun 15;3(5):568-576. doi: 10.1016/j.hroo.2022.06.001. eCollection 2022 Oct. Heart Rhythm O2. 2022. PMID: 36340488 Free PMC article.

4

217th ENMC International Workshop: RYR1-related myopathies, Naarden, The Netherlands, 29-31 January 2016.

Jungbluth H, Dowling JJ, Ferreiro A, Muntoni F; RYR1 Myopathy Consortium. Jungbluth H, et al. Neuromuscul Disord. 2016 Sep;26(9):624-33. doi: 10.1016/j.nmd.2016.06.001. Epub 2016 Jun 7. Neuromuscul Disord. 2016. PMID: 27377473 No abstract available.

5

Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery.

Karkouti K, Yau TM, Riazi S, Dattilo KM, Wasowicz M, Meineri M, McCluskey SA, Wijeysundera DN, van Rensburg A, Beattie WS. Karkouti K, et al. Among authors: riazi s. Can J Anaesth. 2006 Aug;53(8):802-9. doi: 10.1007/BF03022797. Can J Anaesth. 2006. PMID: 16873347

6

Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa.

Riazi S, Karkouti K, Heggie J. Riazi S, et al. Can J Anaesth. 2006 Sep;53(9):881-4. doi: 10.1007/BF03022830. Can J Anaesth. 2006. PMID: 16960265

7

A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.

Toppin PJ, Chandy TT, Ghanekar A, Kraeva N, Beattie WS, Riazi S. Toppin PJ, et al. Among authors: riazi s. Can J Anaesth. 2010 Jul;57(7):689-93. doi: 10.1007/s12630-010-9314-4. Epub 2010 Apr 30. Can J Anaesth. 2010. PMID: 20431982

8

Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.

Kraeva N, Riazi S, Loke J, Frodis W, Crossan ML, Nolan K, Kraev A, Maclennan DH. Kraeva N, et al. Among authors: riazi s. Can J Anaesth. 2011 Jun;58(6):504-13. doi: 10.1007/s12630-011-9494-6. Epub 2011 Mar 31. Can J Anaesth. 2011. PMID: 21455645

9

Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.

Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Riazi S, et al. Anesth Analg. 2014 Feb;118(2):381-387. doi: 10.1213/ANE.0b013e3182937d8b. Anesth Analg. 2014. PMID: 23842196

10

Analysis of histomorphology in malignant hyperthermia-susceptible patients.

Orlov D, Keith J, Rosen D, Croul S, Kraeva N, Riazi S. Orlov D, et al. Among authors: riazi s. Can J Anaesth. 2013 Oct;60(10):982-9. doi: 10.1007/s12630-013-0005-9. Epub 2013 Jul 26. Can J Anaesth. 2013. PMID: 23888335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters